Dr. Bering is the medical director of Hypertrophic Cardiomyopathy at MedStar Washington Hospital Center and assistant professor of Clinical Medicine at Georgetown University School of Medicine.
He joined MedStar Washington Hospital Center in 2018 as a clinical cardiologist in the section of cardiovascular imaging. He became the medical director of hypertrophic cardiomyopathy (HCM) in 2022 with prior mentorship from HCM centers of excellence directors in his general cardiology and imaging fellowships. Besides HCM, his clinical work includes cardiovascular magnetic resonance imaging, diagnostic echocardiography, and intraprocedural transesophageal echocardiography.
Dr. Bering received his medical degree from the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. He performed his internal medicine residency and cardiovascular medicine fellowship at the University of Maryland Medical Center in Baltimore, MD, where he was the chief fellow. He completed a subspecialty cardiac magnetic resonance imaging fellowship at the University of Pittsburgh Medical Center Presbyterian Hospital in Pittsburgh, PA, and is an Alpha Omega Alpha Medical Honor Society member.
Research Interests
Dr. Bering's research interests include the following:
- Hypertrophic cardiomyopathy
- Cardiac magnetic resonance imaging
- Structural heart disease
Selected Research
Site primary investigator for the Cytokinetics CY 6031 protocol (SEQUOIA HCM trial): A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of CK-3773274 in Adults with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction. Site Principal Investigator. 2022, May 11 to present.
Site primary investigator for the Cytokinetics CY 6022 protocol (FOREST HCM study): An Open-Label Study of CK-3773274 for Patients with Symptomatic Hypertrophic Cardiomyopathy. Site Principal Investigator. Initiation date 2023, March 01.
Research Areas
- Cardiovascular